Do we understand the personalized medicine paradigm?

Publisher： John Wiley & Sons Inc

E-ISSN： 1469-3178|16|2|133-136

ISSN： 1469-221x

Source： EMBO REPORTS, Vol.16, Iss.2, 2015-02, pp. : 133-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The controversial role of the Polycomb group proteins in transcription and cancer: how much do we not understand Polycomb proteins?

By  

FEBS JOURNAL (ELECTRONIC), Vol. 282, Iss. 9, 2015-05 ,pp. : 1703-1722

John Wiley & Sons Inc

Access to resources Recommend Favorite

Making personalized medicine more affordable

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1346, Iss. 1, 2015-06 ,pp. : 81-89

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteomics of pulmonary hypertension: Could personalized profiles lead to personalized medicine?

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 9, Iss. 1-2, 2015-02 ,pp. : 111-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

The potential of the riboSNitch in personalized medicine

By  

WILEY INTERDISCIPLINARY REVIEWS: RNA (ELECTRONIC), Vol. 6, Iss. 5, 2015-09 ,pp. : 517-532

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genomic Discoveries and Personalized Medicine in Neurological Diseases

By Zhang Li   Hong Huixiao  

Pharmaceutics, Vol. 7, Iss. 4, 2015-12 ,pp. : 542-553

MDPI

Access to resources Recommend Favorite